Cite

HARVARD Citation

    Reggia, R. et al. (n.d.). SAT0205 Failure of the Switch from the Intravenous to the Subcutaneous Formulation of Abatacept due to a Disease Reactivation: Our Experience. Annals of the rheumatic diseases. p. 731. [Online]. 
  
Back to record